No TARDBP mutations in a French Canadian population of patients with Parkinson disease.
Kabashi
Edor
E
Daoud
Hussein
H
Rivière
Jean-Baptiste
JB
Valdmanis
Paul N
PN
Valdamanis
Paul N
PN
Bourgouin
Patrick
P
Provencher
Pierre
P
Pourcher
Emmanuelle
E
Dion
Patrick
P
Dupré
Nicolas
N
Rouleau
Guy A
GA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D001923:Brain Chemistry / Q000235:genetics*; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D016631:Lewy Bodies / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000208:ethnology* / Q000235:genetics*; D044382:Population Groups / Q000235:genetics; D011792:Quebec
D004268:DNA-Binding Proteins; D005819:Genetic Markers